指南与共识消化系统肿瘤

结直肠癌免疫亚型与共识分子亚型的相关性揭示新肿瘤微环境特征及预后治疗意义

The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
指南 / 共识 · Eur J Cancer · 2019-11-01

基于TCGA结直肠癌数据(N=625),分析六种免疫亚型(IS)与共识分子亚型(CMS)的对应关系。CRC中仅识别出5种IS,以C1愈合型(77%)和C2干扰素-γ主导型(17%)为主;CMS1中C2占53%,CMS2中C1占91%。IS对CRC预后的分层能力强于CMS分类。

要点

  • CRC中仅识别5种免疫亚型,C1愈合型占77%、C2干扰素-γ主导型占17%。
  • CMS1以C2为主(53%),CMS2以C1为主(91%),C6 TGF-β主导型均属CMS4(2.3%)。
  • IS对CRC预后的分层能力优于CMS分类,C2免疫活化通路增强且M1/M2极化最高。

核心结论

  • IS与CMS联合可更精确地对CRC患者进行临床和生物学分层,有助于优化个体化治疗。

研究设计与样本

  • 回顾性分析TCGA结直肠癌队列(N=625),获取CMS与IS分型及临床分子信息。
  • 采用免疫细胞群分析、差异基因表达和基因集富集分析表征IS特征。

主要发现

  • CRC中仅识别5种IS,以C1愈合型(77%)和C2干扰素-γ主导型(17%)为主。
  • CMS1中C2占比最高(53%),CMS2中C1占91%,CMS3中C3炎症型占7%、C4淋巴细胞耗竭型占4%。
  • 所有C6 TGF-β主导型病例均属于CMS4(2.3%)。
  • IS对CRC预后的分层能力明显强于CMS分类,且与全局TCGA报道的预后意义不同。
  • C2具有更高的CD8、活化CD4、滤泡辅助T、调节性T及中性粒细胞密度和最高M1/M2极化。

关键数值与推荐

  • C2富集免疫系统、凋亡、DNA修复、mTOR信号和氧化磷酸化通路,C1更依赖代谢通路。

临床怎么用

  • 可将IS与CMS联合用于CRC患者分层,辅助判断预后并指导个体化治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Solid tumour growth is the consequence of a complex interplay between cancer cells and their microenvironment. Recently, a new global transcriptomic immune classification of solid tumours has identified six immune subtypes (ISs) (C1-C6). Our aim was to specifically characterise ISs in colorectal cancer (CRC) and assess their interplay with the consensus molecular subtypes (CMSs). METHODS: Clinical and molecular information, including CMSs and ISs, were obtained from The Cancer Genome Atlas (TCGA) (N = 625). Immune cell populations, differential gene expression and gene set enrichment analysis were performed to characterise ISs in the global CRC population by using CMSs. RESULTS: Only 5 ISs were identified in CRC, predominantly C1 wound healing (77%) and C2 IFN-γ dominant (17%). CMS1 showed the highest proportion of C2 (53%), whereas C1 was particularly dominant in CMS2 (91%). CMS3 had the highest representation of C3 inflammatory (7%) and C4 lymphocyte depleted ISs (4%), whereas all C6 TGF-β dominant cases belonged to CMS4 (2.3%). Prognostic relevance of ISs in CRC substantially differed from that reported for the global TCGA, and ISs had a greater ability to stratify the prognosis of CRC patients than CMS classification. C2 had higher densities of CD8, CD4 activated, follicular helper T cells, regulatory T cells and neutrophils and the highest M1/M2 polarisation. C2 had a heightened activation of pathways related to the immune system, apoptosis and DNA repair, mTOR signalling and oxidative phosphorylation, whereas C1 was more dependent of metabolic pathways. CONCLUSIONS: The correlation of IS and CMS allows a more precise categorisation of patients with relevant clinical and biological implications, which may be valuable tools to improve tailored therapeutic interventions in CRC patients.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Soldevilla B, Carretero-Puche C, Gomez-Lopez G, et al. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications. Eur J Cancer. 2019. PMID: 31678770. doi:10.1016/j.ejca.2019.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。